concept

CHAPERONE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CHAPERONE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

647Connections

30Hypotheses

0Analyses

50Outgoing

50Incoming

15Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CHAPERONE

Pathway Diagram

graph TD
    CHAPERONE["CHAPERONE"]
    ERK["ERK"] -->|"inhibits"| CHAPERONE
    ERK1["ERK1"] -->|"inhibits"| CHAPERONE
    HSPA1A["HSPA1A"] -->|"activates"| CHAPERONE
    HSP70["HSP70"] -->|"expressed in"| CHAPERONE
    ATG10["ATG10"] -->|"activates"| CHAPERONE
    ATG12["ATG12"] -->|"activates"| CHAPERONE
    CALCINEURIN["CALCINEURIN"] -->|"activates"| CHAPERONE
    BIP["BIP"] -->|"activates"| CHAPERONE
    C_JUN["C-JUN"] -->|"activates"| CHAPERONE

Outgoing (51)

Target	Relation	Type	Str
CHAPERONE-MEDIATED AUTOPHAGY	regulates	concept	0.50
disease	inhibits	disease	0.50
SYNUCLEIN	inhibits	concept	0.50
α-SYNUCLEIN	inhibits	concept	0.50
Proteins	inhibits	protein	0.50
AUTOPHAGOSOME	activates	concept	0.50
Proteostasis	activates	process	0.50
AMYLOID-β	interacts_with	concept	0.50
CELL DEATH	associated_with	concept	0.50
Infection	associated_with	disease	0.50
AMYLOID-β	inhibits	concept	0.50
HER2	inhibits	concept	0.50
Neuroblastoma	activates	disease	0.50
SELECTIVE AUTOPHAGY	activates	concept	0.50
STEM CELLS	activates	concept	0.50
RAPAMYCIN	activates	concept	0.50
PEROXISOME	activates	concept	0.50
Proteins	activates	protein	0.50
GSK3	activates	concept	0.50
CHAPERONE-MEDIATED AUTOPHAGY	activates	concept	0.50
disease	associated_with	disease	0.50
Proteins	associated_with	protein	0.50
FBXW7	regulates	concept	0.50
FBXW7	activates	concept	0.50
Fatty Liver	interacts_with	disease	0.50
AMYLOID BETA	activates	concept	0.50
SYNUCLEIN	activates	concept	0.50
LEWY BODY	activates	concept	0.50
α-SYNUCLEIN	activates	concept	0.50
ACHE	inhibits	concept	0.50
Proteins	decreases_risk	protein	0.50
disease	activates	disease	0.50
PPP3	activates	concept	0.50
Proteins	interacts_with	protein	0.50
CHAPERONE-MEDIATED AUTOPHAGY	interacts_with	concept	0.50
NEURONS	expressed_in	concept	0.50
SYNUCLEIN	expressed_in	concept	0.50
LEWY BODY	expressed_in	concept	0.50
α-SYNUCLEIN	expressed_in	concept	0.50
Proteostasis	associated_with	process	0.50
DENDRITE	associated_with	concept	0.50
Proteostasis	regulates	process	0.50
Protein Folding	regulates	pathway	0.50
NEURONS	activates	concept	0.50
DENDRITE	activates	concept	0.50
disease	interacts_with	disease	0.50
Protein Folding	interacts_with	pathway	0.50
PARKINSON'S	interacts_with	concept	0.50
ENDOPLASMIC RETICULUM STRESS	inhibits	concept	0.50
ENDOPLASMIC RETICULUM	inhibits	concept	0.50

Incoming (596)

Source	Relation	Type	Str
Als	therapeutic_target	disease	1.00
AUTOPHAGY	activates	gene	1.00
AUTOPHAGY	regulates	gene	1.00
OXIDATIVE STRESS	regulates	gene	1.00
NEURODEGENERATION	activates	gene	0.90
Cancer	regulates	disease	0.90
NEURODEGENERATION	regulates	gene	0.90
Neurodegeneration	regulates	disease	0.90
Parkinson	therapeutic_target	disease	0.90
PARKINSON	therapeutic_target	gene	0.90
Cancer	therapeutic_target	disease	0.85
Als	regulates	disease	0.85
Als	activates	disease	0.85
Neurodegeneration	activates	disease	0.85
Alzheimer	activates	disease	0.85
P62	regulates	gene	0.80
Tumor	inhibits	disease	0.80
NEURODEGENERATIVE DISORDERS	regulates	gene	0.80
ALZHEIMER	activates	gene	0.80
ALZHEIMER'S DISEASE	activates	gene	0.80
Aging	activates	disease	0.80
APOPTOSIS	activates	gene	0.80
GENES	activates	gene	0.80
OXIDATIVE STRESS	therapeutic_target	gene	0.80
UBIQUITIN	activates	gene	0.80
ROS	regulates	gene	0.80
LYSOSOME	regulates	gene	0.80
PARKINSON'S DISEASE	therapeutic_target	gene	0.80
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	0.80
CANCER	regulates	gene	0.80
Cancer	inhibits	disease	0.75
MDM2	therapeutic_target	gene	0.70
NRF2	inhibits	gene	0.70
CANCER	therapeutic_target	gene	0.70
P62	associated_with	gene	0.70
CANCER	inhibits	gene	0.70
P53	therapeutic_target	gene	0.70
Colorectal Cancer	inhibits	disease	0.70
AUTOPHAGY	therapeutic_target	gene	0.70
LC3	regulates	gene	0.70
NRF2	regulates	gene	0.70
Als	interacts_with	disease	0.70
Tumor	regulates	disease	0.70
DJ-1	regulates	gene	0.70
PI3K	regulates	gene	0.70
BAG3	associated_with	gene	0.70
Neurodegeneration	therapeutic_target	disease	0.70
MITOPHAGY	regulates	gene	0.70
UBIQUITIN	regulates	gene	0.70
AKT	regulates	gene	0.70

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
HSP90-cochaperone complexes preferentially stabilize interme	0.840	protein-biochemistry	Do chaperones selectively recognize path
J-protein co-chaperone system mediates selective autophagy t	0.831	protein-biochemistry	Do chaperones selectively recognize path
APOE4 Allosteric Rescue via Small Molecule Chaperones	0.765	neurodegeneration	APOE4 structural biology and therapeutic
Proteostasis Enhancement via APOE Chaperone Targeting	0.724	neurodegeneration	Mechanistic role of APOE in neurodegener
ASO-Mediated Exon Skipping to Restore FUS-TAZ Chaperone Axis	0.720	neurodegeneration	How does FUS loss-of-function in TAZ reg

Chaperone-Mediated APOE4 Refolding Enhancement	0.680	neurodegeneration	APOE4 structural biology and therapeutic
Autophagic Flux Enhancement Synergizes With Chaperones to Cl	0.649	protein-folding	Can chaperone enhancement approaches ove
J-protein co-chaperone repertoire enables selective recognit	0.642	protein-biochemistry	Do chaperones selectively recognize path
Chaperone-Degradation Coupling Prevents Aggregate Persistenc	0.632	protein-folding	Can chaperone enhancement approaches ove
Rutin enhances chaperone and autophagic clearance of misfold	0.599	neurodegeneration	What is the molecular mechanism by which
H4: Age-Related Hsp70 Chaperone Decline Blocks Granule Rever	0.577	neurodegeneration	How do pathological stress granules tran
Multi-Chaperone System Co-Activation Prevents Saturation Thr	0.549	protein-folding	Can chaperone enhancement approaches ove
HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor	0.544	neurodegeneration	Protein aggregation cross-seeding across
Transient Chaperone Priming Prior to Seed Inoculation Preven	0.535	protein-folding	Can chaperone enhancement approaches ove
APOE4 Structural Remodeling via HSP70 Chaperone Enhancement	0.486	molecular-biology	Is APOE4's reduced lipid binding pathoge
Chaperone Network Reprogramming Therapy	0.455	neurodegeneration	How do host cell factors influence the c
Competitive Co-chaperone Displacement	0.455	drug-discovery	What are the minimal structural requirem
Co-chaperone Hijacking Strategy	0.455	drug-discovery	What are the minimal structural requirem
Hsp70 cochaperone BAG3-mediated Autophagy Activation for Syn	0.447	proteomics	Quantitative proteomics of the aging syn
Seed Conformational Heterogeneity Explains Variable Chaperon	0.435	protein-folding	Can chaperone enhancement approaches ove
FUS Mutations Impede G3BP1's Chaperone Function, Exposing Ne	0.430	neurodegeneration	How do disease-associated mutations in G
HSP70/HSP40 Chaperone Complex Secretion	0.380	neurodegeneration	Which specific factors in conditioned me
Chaperone-Autophagy Coupling Prevents Aggregate Persistence	0.380	protein-folding	Can chaperone enhancement approaches ove
J-protein co-chaperone repertoire drives ATP-independent dis	0.380	protein-biochemistry	Do chaperones selectively recognize path
Kinetic Threshold Model Predicts CHIP-Mediated Clearance Req	0.380	protein-folding	Can chaperone enhancement approaches ove
Chaperone-Autophagy Coupling Prevents Aggregate Persistence	0.380	protein-folding	Can chaperone enhancement approaches ove
Kinetic Threshold Model of Chaperone-CHIP Coupling: ATP Cycl	0.380	protein-folding	Can chaperone enhancement approaches ove
LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy	0.000	proteomics	Quantitative proteomics of the aging syn
Chaperone-Mediated APOE4 Refolding Therapy	0.000	-	APOE4 structural biology and therapeutic
Chaperone-Mediated Interaction Rescue	0.000	-	How do protein-protein interactions dete

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (15)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
GWAS of plasma NfL in East Asian cohort	exploratory	Alzheimer's disease	0.950	0.00	human patients - East Asian co	proposed	N/A
GWAS of plasma pTau217 in East Asian cohort	exploratory	Alzheimer's disease	0.950	0.00	human patients - East Asian co	proposed	N/A
Dairy intake and dementia risk in Malmö Diet and Cancer cohort	clinical	Alzheimer's disease	0.950	0.00	Swedish community-based adults	proposed	N/A
GWAS of plasma pTau181 in East Asian cohort	exploratory	Alzheimer's disease	0.950	0.00	human patients - East Asian co	proposed	N/A
GWAS of plasma GFAP in East Asian cohort	exploratory	Alzheimer's disease	0.950	0.00	human patients - East Asian co	proposed	N/A
KEEPS Continuation: Long-term effects of menopausal hormone therapy on	clinical	Alzheimer's disease	0.950	0.00	recently menopausal women with	proposed	N/A
GWAS of composite biomarker score	exploratory	Alzheimer's disease	0.900	0.00	human patients - East Asian co	proposed	N/A
RBG treatment in ApoE-/- atherosclerosis mouse model	validation	atherosclerosis	0.900	0.00	ApoE-/- mice	proposed	N/A
APOE4 association with TDP-43 pathology in AD	exploratory	Alzheimer's disease	0.750	0.00	human patients	proposed	N/A
s:** - Biochemical binding assays measuring PROTAC selectivity for APO	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000
s:** - Dose-response studies showing therapeutic window without toxici	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investig	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,100,000
ApoE4 Function in Alzheimer's Disease	validation	Alzheimer's Disease	0.400	0.50	mouse	proposed	$360,000
Down Syndrome Alzheimer's Disease: Mechanisms and Therapeutic Timing	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,730,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of [PMID:30335591]	Rusmini P, Cortese K, Crippa V, Cristofa	Autophagy	2019	2
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685]	Litvinchuk A, Suh JH, Guo JL, Lin K, Dav	Neuron	2024	1
The cell biology of APOE in the brain. [PMID:37805344]	Windham IA, Cohen S	Trends Cell Biol	2024	1
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegene [PMID:37957317]	Maxine R Nelson, Peng Liu, Ayushi Agrawa	Nature neuroscience	2023	1
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485]	Serrano-Pozo A, Das S, Hyman BT	Lancet Neurol	2021	1
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [PMID:31564456]	Long JM, Holtzman DM	Cell	2019	1
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. [PMID:31367008]	Yamazaki Y, Zhao N, Caulfield TR, Liu CC	Nat Rev Neurol	2019	1
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associate [PMID:41905188]	Cetindag AC, Schipke CG, Esselmann H, Kr	The journal of prevention of A	2026	0
ASS1 Promotes Atherosclerotic Inflammation Through the NLRP3/IL-33/ST2 Axis in O [PMID:41914296]	Wu S, Han F, Qiao Z, Yuan S, Bian X, Zha	Frontiers in bioscience (Landm	2026	0
Perioperative polygenic and APOE-based genetic risk assessment for neurocognitiv [PMID:40562635]	Thedim M, Hu J, Maher M, Wiener-Kronish	Br J Anaesth	2026	0
Increased genetic protection against Alzheimer's disease in centenarians. [PMID:40615639]	Bae H, Song Z, Ali A, Sasaki T, Tesi N e	Geroscience	2026	0
Integrative machine learning approach to risk prediction for dementia and Alzhei [PMID:40864401]	Stern A, Linial M	Geroscience	2026	0
Restoration of p53 mRNA combined with BRD4 silencing by brain targeted nanocapsu [PMID:41101204]	Sang Y, Cao Y, Li S, Quan Y, Wang S et a	Biomaterials	2026	0
Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β path [PMID:41445196]	Lin Z, Xiong J, Zhang F, Zhang H, Zhu M	Mol Ther	2026	0
Menopause, cognition, and Alzheimer's disease risk. [PMID:41531227]	Samudra N, Vemuri M, Weitlauf J	Curr Opin Obstet Gynecol	2026	0
DPP4-regulated endothelial cell ferroptosis modulates atherosclerosis progressio [PMID:41565199]	Zheng L, Liang K, Peng Y, Jin M, Chen X	J Mol Cell Cardiol	2026	0
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disor [PMID:40145985]	Lozupone M, Leccisotti I, Mollica A, Ber	Neural regeneration research	2026	0
Guhan Yangsheng Jing alleviates sleep deprivation-induced neuronal injury via ne [PMID:41539636]	["Fu X", "Long Q", "Wang Z", "Yan S", "L	Journal of ethnopharmacology	2026	0
Cognitive Decline and Neurodegenerative Markers in Psoriasis: The Role of APOE4 [PMID:41912201]	Sabry HH, Kadhum BQ, Abdulmohsin GN, El-	Dermatology practical & concep	2026	0
Association of Periodontal Pathogens and Their Inflammatory Mediators With Alzhe [PMID:41890452]	Arriaga P, Vianna K, Montez C, Panariell	Cureus	2026	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CHAPERONE in their description or question text

Chaperone-Mediated APOE4 Refolding Enhancement

Score: 0.680 · neurodegeneration · 2026-04-02

## Mechanistic Overview Chaperone-Mediated APOE4 Refolding Enhancement starts from the claim that modulating HSPA1A, HSP

Autophagic Flux Enhancement Synergizes With Chaperones to Clear High-Molecular-W

Score: 0.649 · protein-folding · 2026-04-22

**Molecular Mechanism and Rationale** The proposed therapeutic strategy exploits the complementary relationship between

J-protein co-chaperone repertoire enables selective recognition of pathogenic co

Score: 0.642 · protein-biochemistry · 2026-04-21

**Molecular Mechanism and Rationale** The J-protein co-chaperone system represents a sophisticated cellular quality con

Chaperone-Degradation Coupling Prevents Aggregate Persistence by Shunting Seeds

Score: 0.632 · protein-folding · 2026-04-22

**Molecular Mechanism and Rationale** The chaperone-degradation coupling hypothesis centers on the critical interaction

Rutin enhances chaperone and autophagic clearance of misfolded tau

Score: 0.599 · neurodegeneration · 2026-04-25

The compound acts primarily through HSP70 and lysosomal proteostasis pathways, reducing seeded aggregate burden in intac

H4: Age-Related Hsp70 Chaperone Decline Blocks Granule Reversibility

Score: 0.577 · neurodegeneration · 2026-04-22

## Mechanistic Overview H4: Age-Related Hsp70 Chaperone Decline Blocks Granule Reversibility starts from the claim that

Multi-Chaperone System Co-Activation Prevents Saturation Through Complementary S

Score: 0.549 · protein-folding · 2026-04-22

## Mechanistic Overview Multi-Chaperone System Co-Activation Prevents Saturation Through Complementary Substrate Recogni

HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor

Score: 0.544 · neurodegeneration · 2026-04-02

DNAJB6 specifically recognizes and suppresses amyloidogenic β-sheet conformations shared across tau, α-synuclein, and TD

Transient Chaperone Priming Prior to Seed Inoculation Prevents Propagation by Re

Score: 0.535 · protein-folding · 2026-04-22

## Mechanistic Overview Transient Chaperone Priming Prior to Seed Inoculation Prevents Propagation by Reshaping Neuronal

APOE4 Structural Remodeling via HSP70 Chaperone Enhancement Strategy

Score: 0.486 · molecular-biology · 2026-04-21

## Mechanistic Overview APOE4 Structural Remodeling via HSP70 Chaperone Enhancement Strategy starts from the claim that

Chaperone Network Reprogramming Therapy

Score: 0.455 · neurodegeneration · 2026-04-27

Selective enhancement of chaperone-co-chaperone complexes to convert pathological conformations to benign or degradable

Competitive Co-chaperone Displacement

Score: 0.455 · drug-discovery · 2026-04-27

Small molecules that competitively displace tau-stabilizing immunophilins (FKBP51) from HSP90 while recruiting tau-desta

Co-chaperone Hijacking Strategy

Score: 0.455 · drug-discovery · 2026-04-27

Bifunctional PROTACs that simultaneously bind HSP70's substrate-binding domain and recruit CHIP ubiquitin ligase specifi

Hsp70 cochaperone BAG3-mediated Autophagy Activation for Synaptic Protein Qualit

Score: 0.447 · proteomics · 2026-04-25

Hsp70 cochaperone BAG3-mediated Autophagy Activation for Synaptic Protein Quality Control

Seed Conformational Heterogeneity Explains Variable Chaperone Susceptibility—Str

Score: 0.435 · protein-folding · 2026-04-22

## Mechanistic Overview Seed Conformational Heterogeneity Explains Variable Chaperone Susceptibility—Strain-Specific Tar